Baricitinib
BARICITINIB
ORAL
HUMAN PRESCRIPTION DRUG
Baricitinib is an FDA drug label for the active ingredient BARICITINIB manufactured by Eli Lilly and Company administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220510.
- Generic name
- BARICITINIB
- Manufacturer
- Eli Lilly and Company
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 0002-6885
- Application
- N/A
- Label effective
- 20220510
Indications & Usage
Not available.
Dosage & Administration
Not available.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.